IPO Premiums
IPO calendar
CHCHCLListed

Cian Healthcare Limited

Bookbuilding IPO · BSE

Price band
₹61 - ₹65
Lot size
2,000 shares
Issue amount
₹38 cr
Total subscription
0×
Current price₹28.62
Listing price ₹62
Watch live price ↗
Opens
2 May 2019
Closes
15 May 2019
Allotment
20 May 2019
Listing
23 May 2019

Offer at a glance

Issue overview

Issue size
62,16,000 shares
Face value
₹10 per share
Minimum investment
₹1,22,000
Fresh issue
₹0 cr
Offer for sale
₹0 cr
Registrar
Bigshare Services Private Limited
Listing exchange
BSE
Maximum investment
₹1,30,000
Issue type
Bookbuilding IPO
Shares before issue
1,71,44,764
Shares after issue
2,33,60,764

Lot sizes

CategoryLotsSharesAmount
RETAIL12,000₹1,30,000
HNI24,000₹2,60,000

Share reservation

Market Maker5.08%
HNI47.46%
RETAIL47.46%

Subscription & GMP

Subscription by category

Total subscribed0×

Subscription figures are awaiting publication.

GMP history

00.5126 Dec: ₹0
26 Dec₹026 Dec

Financial performance

Company financials

in Lakhs · Reported periods may include interim results.

Revenue & profitin Lakhs
02,0004,0006,000Mar-16 · Revenue: 4,668.21Mar-16 · Profit after tax: 137.2Mar-16Mar-17 · Revenue: 5,178.32Mar-17 · Profit after tax: 223.64Mar-17Mar-18 · Revenue: 5,941.7Mar-18 · Profit after tax: 375.65Mar-18Dec-18 · Revenue: 4,407.21Dec-18 · Profit after tax: 525.03Dec-18
RevenueProfit after tax

Company information

Company profile

Cian Healthcare Limited, incorporated in 2003, is a multinational manufacturing company certified by WHO-GMP and ISO 9001:2015, specializing in food supplements, sexual wellness, cosmeceuticals, nutraceuticals, ayurvedic, and pharmaceutical products. The company develops, manufactures, and commercializes products across 12 therapeutic divisions and 10 sales divisions, operating under its own brand while also engaging in government supplies, exports, and third-party manufacturing. Its product portfolio includes sachets, gels, lotions, creams, ointments, liquid orals, capsules, and tablets, and it holds a special license to manufacture veterinary products such as Venky's and SAVAvet. As of March 31, 2018, sales were comprised of 37% contract manufacturing, 24% government supplies, 23% franchise business, and 16% export sales.

Strengths

  • Pan-India Presence: Operates across the country.
  • Experienced Promoters: 15 years of industry expertise.
  • Strong Purchasing Power: Effective sourcing capabilities.
  • Robust Distribution: Well-established distribution network.
  • Low-Cost Operations: Maintains cost-efficient business processes.

Promoters

Mr. Suraj Zanwar

Mrs. Kavita Zanwar

Registrar & documents

Lead manager

Fedex Securities Private Limited

Registered office

Milkat No. 3339, Block No.1, From South Side, C.S.No.227 /2 + 3A, Harpale Park, Opp Berger Paint, Phursungi, Pune- 412308

020-41471234

[email protected]Company website ↗

Understanding CHCL IPO data

Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.